These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29044884)

  • 1. A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
    Elliott J; Finotello R
    Vet Comp Oncol; 2018 Mar; 16(1):E144-E151. PubMed ID: 29044884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.
    Parsons-Doherty M; Poirier VJ; Monteith G
    Can Vet J; 2014 Feb; 55(2):175-80. PubMed ID: 24489398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
    Smallwood K; Harper A; Blackwood L
    J Feline Med Surg; 2021 Aug; 23(8):722-729. PubMed ID: 33176543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.
    Alvarez FJ; Kisseberth WC; Gallant SL; Couto CG
    J Vet Intern Med; 2006; 20(5):1178-83. PubMed ID: 17063713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
    Smallwood K; Tanis JB; Grant IA; Blackwood L; Killick DR; Amores-Fuster I; Elliott J; Mas A; Harper A; Marrington M; Finotello R
    Vet Comp Oncol; 2019 Jun; 17(2):165-173. PubMed ID: 30666777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
    Martin OA; Price J
    J Feline Med Surg; 2018 Oct; 20(10):934-939. PubMed ID: 29065803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus.
    Horta RS; Souza LM; Sena BV; Almeida IO; Jaretta TA; Pimenta MM; Reche Júnior A
    J Feline Med Surg; 2021 Feb; 23(2):86-97. PubMed ID: 32684120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma.
    Webster J; McNaught KA; Morris JS
    J Feline Med Surg; 2024 Apr; 26(4):1098612X241234614. PubMed ID: 38647264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma in cats treated with a weekly cyclophosphamide-, vincristine-, and prednisone-based protocol: 114 cases (1998-2008).
    Waite AH; Jackson K; Gregor TP; Krick EL
    J Am Vet Med Assoc; 2013 Apr; 242(8):1104-9. PubMed ID: 23547674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
    Simon D; Eberle N; Laacke-Singer L; Nolte I
    J Vet Intern Med; 2008; 22(2):394-400. PubMed ID: 18312554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
    Kirschey S; Flohr T; Wolf HH; Frickhofen N; Gramatzki M; Link H; Basara N; Peter N; Meyer RG; Schmitz N; Weidmann E; Banat A; Schulz A; Kolbe K; Derigs G; Theobald M; Hess G
    Br J Haematol; 2015 Mar; 168(6):824-34. PubMed ID: 25546611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
    Schmitz N; Pfistner B; Sextro M; Sieber M; Carella AM; Haenel M; Boissevain F; Zschaber R; Müller P; Kirchner H; Lohri A; Decker S; Koch B; Hasenclever D; Goldstone AH; Diehl V; ;
    Lancet; 2002 Jun; 359(9323):2065-71. PubMed ID: 12086759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma: new results with an old protocol.
    Teske E; van Straten G; van Noort R; Rutteman GR
    J Vet Intern Med; 2002; 16(2):179-86. PubMed ID: 11899035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats.
    Taylor SS; Goodfellow MR; Browne WJ; Walding B; Murphy S; Tzannes S; Gerou-Ferriani M; Schwartz A; Dobson JM
    J Small Anim Pract; 2009 Nov; 50(11):584-92. PubMed ID: 19891724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
    Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC
    Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
    Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
    Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
    Gillem J; Giuffrida M; Krick E
    Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Evaluation of Melphalan, Vincristine, and Cytarabine Chemotherapy for the Treatment of Relapsed Canine Lymphoma.
    Duckett ME; Curran KM; Bracha S; Leeper HJ
    J Am Anim Hosp Assoc; 2024 Jan; 60(1):7-14. PubMed ID: 38175982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.